Abstract
Background: Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection and remains a leading cause of mortality in intensive care units (ICUs). Although the Sequential Organ Failure Assessment (SOFA) score is widely used for prognostic stratification, organ dysfunction represents a downstream manifestation of sepsis, whereas immune and inflammatory dysregulation may precede overt organ failure. Monocyte distribution width (MDW) is a novel hematological parameter reflecting monocyte activation and is approved for the diagnosis of sepsis; however, its prognostic value and potential role within composite biomarker models in critically ill surgical patients with sepsis remain incompletely defined. Methods: We conducted a prospective, observational, single-center pilot study in two surgical intensive care units between November 2022 and December 2023. Adult patients with sepsis defined according to Sepsis-3 criteria were enrolled. Laboratory and clinical variables—including MDW, neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP), procalcitonin (PCT), and SOFA score—were measured on admission and during the first five days of ICU stay. Patient-level median values across five days were used for analysis. The primary outcome was in-hospital mortality. Prognostic performance was assessed using receiver operating characteristic (ROC) curve analysis and logistic regression. A composite bioscore was constructed by combining dichotomized MDW, NLR, CRP, and PCT values. Results: Sixty patients were included; 24 (40%) died during hospitalization. Non-survivors were older and had significantly higher SOFA scores. MDW, NLR, CRP, and PCT were significantly higher in non-survivors. SOFA demonstrated the strongest discriminative ability for mortality prediction (AUC 0.839, 95% CI 0.730–0.948). Among biomarkers, NLR (AUC 0.741) and PCT (AUC 0.714) showed good discriminative performance, while MDW (AUC 0.690) and CRP (AUC 0.662) showed moderate discrimination; MDW exhibited the highest specificity (80.6%). In multivariable analysis with individual biomarkers, only SOFA remained an independent predictor of mortality. The composite bioscore demonstrated good discriminative ability (AUC 0.805) and, when evaluated alongside SOFA, remained independently associated with fatal outcome (OR 11.92, 95% CI 1.76–80.75); however, given the modest sample size and wide confidence intervals, this finding should be interpreted with caution. Repeated-measures correlation analysis revealed no strong collinearity among biomarkers. Conclusions: A composite bioscore incorporating MDW, NLR, CRP, and PCT provides prognostic information comparable to SOFA and remains independently associated with mortality. This approach may complement organ dysfunction-based assessment and support early risk stratification in sepsis.